Therapeutic Lifecycle SIG

The scope of the Decentralized Clinical Trials (DCT) Special Interest Group is evolving to focus holistically on the full lifecycle of therapeutic development, from clinical trials to in-market use. Initial work will focus on clinical research, regulatory submission, in-market pharmaceuticals, and connecting research technology solutions to in-market technology solutions.

Please join us January 24th to learn about the new focus of the SIG, how you can participate, and prioritize projects for 2023.